Site Search
Professionals 310 results
Capabilities 61 results
Practice Area
Our nationally recognized Appellate & Critical Motions (ACM) Practice delivers sophisticated legal advocacy and analysis before trial, at trial, and on appeal. From state trial courts to the U.S. Supreme Court, our ACM attorneys identify, preserve, and present the critical legal issues that can make the difference between winning and losing.
Practice Area
Trial skills matter—even in a world where few disputes ever see the inside of a courtroom. Winston has built a reputation as a trial lawyers’ firm, featuring seasoned litigators who leverage extensive courtroom experience to meet our clients’ business and legal objectives. Our long history of taking cases to trial—and winning—provides our clients with tremendous settlement leverage with their adversaries, as well as a substantial likelihood of a favorable resolution if, and when, they go to trial.
Practice Area
For decades, Winston has represented a broad array of clients in the insurance industry, including some of the world’s largest and best-known insurers. Our prowess in and understanding of the insurance industry encompasses not only its products, practices, and services, but also the increasing challenges posed by a world increasingly characterized by a fast-evolving technological landscape as well as financial, political, and environmental instability. Accordingly, Winston’s lawyers are among the most sought-after in the industry—not only by companies currently facing high-stakes litigations and investigations, but by those looking to take preventive action now in order to mitigate and manage their risk in the future.
Experience 45 results
Experience
|May 3, 2024
Winston Represented MCE Holdings in its Acquisition of General Machinery
Experience
|March 31, 2024
Winston Represented MCE Holdings in its Acquisition of Daughtridge Sales Company
Insights & News 1,802 results
In the Media
|December 4, 2024
|Less Than 1 Min Read
Winston Partner to Join Webinar On Consolidated Appropriations Act
On December 4, 2024, Winston Partner Amy Gordon will be participating in a webinar discussing the Consolidated Appropriations Act (CAA). Amy, along with a team of industry experts, will discuss:
Webinar
|November 21, 2024
2025 Compliance Countdown: Critical Steps for Annual Reports and Proxy Disclosures
Winston & Strawn invites you to attend an online discussion, hosted by members of our Capital Markets and EBEC teams, addressing the following important topics for public companies:
Press Release
|November 18, 2024
|3 Min Read
Director of United States Patent and Trademark Office Kathi Vidal to Rejoin Winston & Strawn
Washington, D.C. & Silicon Valley, CA – November 18, 2024 – Winston & Strawn LLP announced today that Kathi Vidal will rejoin the firm’s Litigation Department as a partner in the firm’s Silicon Valley and Washington, D.C. offices and as a member of the Executive Committee after stepping down from her role as Undersecretary of Commerce for Intellectual Property and Director of the United States Patent and Trademark Office (USPTO). Kathi will rejoin Winston on December 16, 2024.
Other Results 31 results
Site Content
In the product liability context, epidemiology refers to the study of the incidence, distribution, and etiology of disease or harm in human populations. Epidemiological studies include a variety of different study designs, such as prospective and retrospective cohort studies, case-control studies, randomized controlled trials, and meta-analysis. Epidemiology is a critical, and sometimes mandatory, element for establishing general causation.
Site Content
In the product liability context, general causation is the legal and scientific determination of whether the product in question has the inherent capability to cause the alleged injury under certain circumstances. Establishment of general causation is a critical aspect of a plaintiff’s case, and typically requires scientific evidence, such as epidemiology or toxicology, and expert testimony to establish a causal connection between the product’s design, manufacturing, or warnings and the injury or injuries at issue. As contrasted to specific causation, the focus in a general causation inquiry is on whether the product or exposure, as a general matter, can cause the type of injury claimed by the plaintiff. A general causation inquiry does not assess any facts unique to a particular plaintiff.